Vivek Pawar, PhD, is an Executive Director in the Global Evidence and Value Development (GEVD) function at EMD Serono. He co-leads Work Package 7. He leads the oncology development unit within the GEVD team with accountabilities for integrating HTA/payer evidentiary requirements into the clinical development of the company’s oncology portfolio. His team is also responsible for generating the relative effectiveness value package to meet global payer needs and facilitate fast patient access following regulatory approval. Patient-centered outcomes (inclusive of PROs) are a key component of this value package. He previously worked at Bayer HealthCare as well as in health economics consulting at United Health Group. He is looking forward to bring his pharmaceutical industry perspective to WP7 and through this contribute towards ultimately improving health care decision making for patients.